Ready Computing's Channels360 Selected by the Medicaid Innovation Collaborative Out of a Field of Over 100 Applicants
NEW YORK, January 19, 2024 (Newswire.com)
-
Ready Computing, in partnership with the Staten Island PPS, Healthfirst and Samaritan City, has been selected by the Medicaid Innovation Collaborative to pilot a programto address the health-related social needs of Medicaid beneficiaries in Staten Island, New York.
"We are thrilled to be selected out of a field of over 100 applicants to help connect vulnerable populations on Staten Island with services and incentives to improve their health status," says Mark Taylor, Vice President of Product Strategy at Ready Computing.
The pilot program is part of MIC’s second cohort focused on Health-Related Social Needs (HRSN). The cohort launched in 2023 and enables state Medicaid programs, managed care plans and other key stakeholders to identify and implement tech-enabled solutions to address the HRSN of Medicaid beneficiaries in Iowa, Kentucky and New York.
The pilot program will launch an outreach program for underserved Healthfirst Medicaid members on Staten Island. Community navigators will use the Ready Computing Channels360 platform to screen, assess and refer members to community-based organizations to address their social needs. A subset of unhoused members will be enrolled in the Samaritan Membership program to provide financial incentives and support to meet their survival needs.
Channels360 is a health and social care platform that connects healthcare providers, health plans, social care workers and community organizations with individuals for better health outcomes and long-term support. The comprehensive platform optimizes care and improves health equity across communities. Learn more about Channels360 at readycomputing.com.
Contact Information:
Michael LaRocca
CEO of Ready Computing [email protected]
(212) 877-3307
MIAMI, January 19, 2024 (Newswire.com)
-
This Valentine's Day, Artizan Joyeria, the Miami-based pioneer in making luxury jewelry accessible, is transforming the essence of love with its captivating campaign, "Start with the Heart Within." Running from January 21st to February 14th, Artizan's Vday campaign is a bold celebration of self-love and empowerment, marked by two exclusive product drops.
In a striking departure from traditional Valentine narratives, Artizan Joyeria’s campaign emphasizes the power and beauty of self-appreciation. “Valentine’s Day is not just about external love; it's a time to honor the love that begins within,” says Keren Yoshua, Artizan Joyeria’s Creative Director. "Our Valentine’s Day campaign is a homage to every individual's journey towards self-love and empowerment. These pieces are symbols of strength, self-acceptance, and personal evolution."
The campaign showcases two exclusive product drop dates, each including a series of pieces that are uniquely designed to embody the themes of individual strength, resilience, freedom, and life's fluidity. Shot in the vibrant city of Madrid by the renowned photographer “El Marco Rojo,” the campaign’s visuals are a showcase of Artizan Joyeria’s innovative and forward-thinking design ethos.
Upholding its commitment to accessible luxury, Artizan Joyeria ensures that this Valentine's Day, the elegance and allure of high fashion are within reach of all who seek it. The "Start with the Heart Within" campaign and its exclusive drops will take place from January 21st to February 14th, exclusively at artizanjoyeria.com.
ABOUT ARTIZAN JOYERIA
Artizan Joyeria is a Miami-based jewelry brand committed to empowering individuality and defying conventions. Since its inception in 2008, the brand has focused on creating unique, fashion-forward, high-quality jewelry pieces that inspire women to embrace their unapologetically authentic selves. Artizan Joyeria seeks to make luxury accessible to all while fostering a strong connection with its customers and leading the way in responsible business practices.
COLUMBUS, Ohio, January 18, 2024 (Newswire.com)
-
Roof Maxx just announced a partnership benefiting the Dave Thomas Foundation for Adoption, a national, nonprofit public charity, and a new Giving Pledge to their customers: When you restore your roof with Roof Maxx, you help find a forever home for a child waiting in foster care.*
Giving Pledge is a heartfelt initiative aimed at making a tangible impact in the lives of the longest-waiting children in foster care. Through a partnership with the Foundation, Roof Maxx pledges to help find forever families for 25,000 children waiting in foster care by 2030.
“Roof Maxx was born out of a desire to help homeowners extend the lifespan of their roof, now we are also creating life-changing opportunities for children,” said Mike Feazel, the company’s CEO and co-founder. The initiative was inspired by Feazel, whose encounter with a boy without a permanent home sparked a commitment to addressing the challenges faced by children and youth in foster care.
In collaboration with the Foundation, Roof Maxx aims to raise awareness about the urgent need for foster care adoption and encourage its corporate employees, dealer network and customer base to get involved in creating positive change.
“Since day one of establishing this incredible partnership, Mike Feazel and the Roof Maxx family have embraced the Foundation’s mission to dramatically increase the number of adoptions of children waiting in North America’s foster care systems. We are profoundly grateful for their commitment to help give more children in foster care the opportunity for a bright future with the support of a forever family,” shared Rita Soronen, President & CEO of the Foundation.
Mike Feazel emphasized, “For customers, it’s easy. If we treat your roof, you immediately make a difference. If the cause really moves a customer, we provide information about how they can contribute further to our giving partner.”
About Roof Maxx
Roof Maxx is a leading roof restoration company that helps homeowners and businesses extend the life of their asphalt roof sustainably and affordably. With a passion for making a positive impact, Roof Maxx's Giving Pledge reflects the company's commitment to social responsibility and community engagement.
About the Dave Thomas Foundation for Adoption
The Dave Thomas Foundation for Adoption is a national, nonprofit public charity dedicated to finding permanent homes for the more than 140,000 children waiting in North America’s foster care systems. Created by Wendy’s® founder Dave Thomas who was adopted, the Foundation implements evidence-based, results-driven national service programs, foster care adoption awareness campaigns and innovative grantmaking. To learn more, visit davethomasfoundation.org.
US market share leader also launches HemoVue, an integrated cloud service that provides blood banks with streamlined management of devices and real-time operational visibility into all blood collection data.
GRASS VALLEY, Calif., January 18, 2024 (Newswire.com)
-
Applied Science, an innovator in transfusion medicine products and services, announced the launch of its latest whole blood collection automation solutions – the HemoFlow 500 Series of blood mixer and scale devices and HemoVue, a cloud-based service that integrates with both the HemoFlow 500 and existing HemoFlow 400 devices to provide real-time operational data and analytics that significantly improve blood collection and related processes.
The launch of the HemoFlow 500 Series and the HemoVue service continues the history of Applied Science delivering innovative solutions to the transfusion medicine market. The combined solution, coupled with its bi-directional communication with existing BECS systems, provides customers with a paperless, automated whole blood collection system that removes the friction of manual data entry, optimizes each donation, eliminates process errors, reduces waste, enhances profitability, and allows phlebotomists to focus on caring for donors.
The HemoFlow 500 Series consists of two models: the HemoFlow 500 and the HemoFlow 500 XS. Both models build upon the innovation and performance of previous HemoFlow devices that today have a 75% share of the US whole blood collection device market and a commanding market share in numerous other countries. Its customers include the American Red Cross, Vitalant, and OneBlood in the United States and the four blood transfusion services of the UK National Health System (NHS), among many others. The 500 Series devices are the industry’s lightest at 3.5 lbs and support up to 230 donations per charge - the longest battery life of any blood mixer and scale device in the market today. Its large, touch-screen display and intuitive operator user interface streamline the donation process to maximize collection efficiency. The HemoFlow 500 XS provides a range of additional advanced features, including multiple device configurations, an integrated barcode scanner, onboard collection record storage, and robust wireless connectivity, enabling data transfer of complete donation records to blood bank information systems, and the HemoVue data service.
The HemoVue service is an extension of the HemoFlow XS that provides streamlined configuration management and software updating of entire fleets of HemoFlow XS devices and real-time operational visibility into all blood collection data across a customer’s entire fixed site and mobile collection operations. The real-time nature of the HemoVue data service, coupled with customizable reports, turns data into actionable intelligence that supports in-the-moment decision-making, including inventory and manufacturing optimization and staff performance management across key metrics, including efficiency, accuracy, and compliance. This information is further available for other planning and analysis activities.
“As with many healthcare sectors, the blood banking industry is facing multiple challenges, many of which can be effectively addressed through greater automation. Solutions that improve efficiency, reduce errors, and better manage donations and inventory accomplish this,” said Jonathan Morgan, President & CEO of Applied Science, Inc. “Our integrated HemoFlow 500 and HemoVue solution is based on inputs from our extensive worldwide customer base and is the first fully automated whole blood collection workflow solution, integrating and managing both pre and post donation data. After thousands of hours of both hardware and software development, we are proud to be able to bring it to serve this lifesaving segment of the healthcare industry.”
The HemoFlow 500 Series is now available for sale in the United States, with rest of world availability planned for later this year. For more information or to schedule a demonstration of the HemoFlow 500 Series or HemoVue, place visit hemoflow.com.
Contact Information:
Hillary Odgers
V.P. - Finance and Administration [email protected]
530.273.8299 X.210 Related Images
Board Will Serve as Strategic Advisors to Accelerate Research for Millions of Patients Living With Chronic, Multisystem Disorders
SALT LAKE CITY, January 18, 2024 (Newswire.com)
-
Metrodora Foundation, a non-profit organization focused on catalyzing scientific collaboration and discovery to find new diagnostics, treatments and cures for chronic, multisystem disorders, today announced the creation of a new Scientific Advisory Board (SAB) that will provide strategic guidance and consult on the Foundation’s research strategy. The SAB brings deep expertise in life sciences, clinical research, technology, and industry to Metrodora, and a commitment to advancing collaborative, data-driven science that improves patient outcomes.
Steve Gardner, PhD, and CEO at PrecisionLife, and Rohit Gupta, Chief Scientific Officer and Head of R&D at Metrodora Institute, will serve as co-chairs of the SAB. Initial members also include: Oved Amitay, former President and CEO, Solve ME/CFS Initiative; Mark Bouzyk, PhD, President, CSO and co-founder, AllaiHealth Inc.; Steven Hicks, MD, PhD, Associate Professor of Pediatrics, Pennsylvania State University College of Medicine; Holden Maecker, PhD, Professor of Microbiology and Immunology, and Director of the Human Immune Monitoring Center, Stanford University; and Peter Rowe, MD, Professor of Pediatrics, Adolescent and Young Adult Medicine, Johns Hopkins University School of Medicine.
"Inherent to Metrodora’s mission is bringing together the most respected leaders from science, technology and business who will help to identify and dismantle the silos and obstacles that slow down progress for patients," said Fidji Simo, President of the Metrodora Foundation. "It will take the brightest minds across diverse fields — from genomics to immunology to artificial intelligence and computational biology — to understand these conditions and develop cures. We couldn’t be more pleased to have this esteemed group of scientific thought leaders collaborating to accelerate critical research for patients living with complex chronic conditions."
By assembling experts with a track record of working across innovative modalities, the SAB will enable Metrodora to develop cutting-edge research programs and improve patient outcomes for patients living with these conditions. Typically triggered by an immune-activating event, such as an infection, surgery, injury or hormone change, these conditions include Long-Covid, ME/CFS, Postural Orthostatic Tachycardia Syndrome (POTS), Migraine and other pain-related conditions, Ehlers-Danlos Syndromes, Mast Cell Activation Syndrome, Sjögrens Syndrome, Irritable Bowel Syndrome (IBS) and Irritable Bowel Disorder (IBD).
“Nothing speaks more deeply to me and to each of us at PrecisionLife than pioneering discovery for the complex, chronic disease population. It’s an honor to serve as Scientific Advisory Board Chair for Metrodora Foundation and to partner with other leaders to develop a robust research program to uncover the biological drivers of these underserved conditions which impact millions,“ said Steve Gardner, CEO of PrecisionLife.
Metrodora Scientific Advisory Board Member Bios
Oved Amitay is a pharmacologist by training, a drug developer by trade, and a patient advocate by choice. He has over 25 years of extensive drug development experience in the biotech industry. Until recently, Amitay served as President and Chief Executive Officer at the Solve ME/CFS Initiative — a national organization devoted to making Myalgic Encephalomyelitis (also known as chronic fatigue syndrome or ME/CFS) and other infection-associated diseases, such as Long-Covid, understood, diagnosed and treatable. Amitay continues to be an advisor to the organization and is currently focused on advancing point-of-care diagnostic tools for these diseases.
Mark Bouzyk, PhD, is President, CSO and co-founder of AllaiHealth Inc. Prior to AllaiHealth, Dr. Bouzyk co-founded and was CSO of AKESOgen, Inc., a genomics and precision medicine company — now part of Tempus Laboratories of Chicago, Illinois. Prior to AKESOgen, Dr. Bouzyk was a faculty member in the Department of Human Genetics at Emory University, Atlanta, Georgia, where he served as a Director of the Emory Biomarker Service Center (EBSC) and Director, Basic Research Shared Core Resources, Winship Cancer Institute of Emory University, as well as Director of the Center for Medical Genomics — which he established. During this time, he was instrumental in the Winship Cancer Institute gaining NIH Cancer Center Status — a first for any institute in the state of Georgia.
Steve Gardner, PhD,has over 30 years’ experience building world-class teams, products and companies in precision medicine, drug discovery and computational biology in the UK, EU and USA. Dr. Gardner specializes in AI-enabled drug discovery and precision medicine, semantic data integration and complex data analytics for life science, healthcare, and clinical decision support. He has developed world-leading genomics, digital health, and informatics technologies, including several patented inventions. He was Global Director of Research Informatics for Astra and was heavily involved in developing some of the core informatics systems used by major genomics companies during the initial Human Genome project. He has worked extensively with major pharma companies on over 30 drug discovery and safety projects.
Rohit Gupta is Chief Scientific Officer and Head of R&D at Metrodora Institute. He brings over 20 years of experience in life sciences. Known as one of the world’s foremost biobanking experts, Gupta has pioneered methodology to rethink how we drive scientific discovery using biospecimens and data as the vehicle for novel clinical applications. He was the principal architect behind the institution's clinical trials and biobanking efforts at Stanford. At UCSF, Gupta rolled out a vision for next-generation biobanking, enabling cutting-edge biomedical research and precision medicine. Gupta has spearheaded innovation, R&D, and business development efforts for several industry companies, most recently as Chief Medical Officer of Spectrum Solutions where he drove a vision to improve access to healthcare through novel medical devices and laboratory diagnostics.
Steve Hicks, MD, PhD,is an Associate Professor, Department of Pediatrics at the Penn State Neuroscience Institute and Director of Research for the Division of Academic General Pediatrics at Penn State University. He oversees studies that involve patients within the general pediatrics clinics. His goal is to safeguard quality care for clinic patients while supervising novel research with the potential to advance delivery of that care. He is also the physician director of the Pediatric Research Resources Office and diagnostic thrust leader for Penn State's Center for Biodevices.
Holden T. Maecker, PhD, is a Professor of Microbiology and Immunology, and Director of the Human Immune Monitoring Center at Stanford University. His research focuses on measuring immune competence, as well as how specific cellular immune responses correlate with immune protection. Dr. Maecker received a BS in Microbiology from Purdue University and a PhD in Cancer Biology from Stanford University. He did postdoctoral work with Ronald and Shoshana Levy at Stanford, and was an Assistant Professor of Biology at Loyola University Chicago, as well as a Senior Scientist at BD Biosciences, San Jose, California.
Peter Rowe, MD, is a Professor of Pediatrics in the Division of Adolescent and Young Adult Medicine at the Johns Hopkins University School of Medicine. He is a graduate of Trinity College, University of Toronto, and the McMaster University School of Medicine, Canada. He completed his residency, fellowship, and Chief Residency in Pediatrics at the Johns Hopkins Hospital. His clinical and research interests for the last 30 years have focused on medical conditions characterized by chronic fatigue. His work has emphasized the importance of a variety of physiologic risk factors for ME/CFS, including orthostatic intolerance, joint hypermobility, allergic inflammation, and adverse biomechanical strain. Since 1996, he has directed the Chronic Fatigue Clinic at the Johns Hopkins Children’s Center where he is the inaugural recipient of the Sunshine Natural Wellbeing Foundation Chair in Chronic Fatigue and Related Disorders. He was a member of the Institute of Medicine Committee on the Diagnostic Criteria for Myalgic Encephalomyelitis/Chronic Fatigue Syndrome.
About the Metrodora Foundation
The Metrodora Foundation is a patient-founded 501(c)(3) non-profit organization catalyzing scientific collaboration and discovery to find cures for chronic, multisystem disorders. The Foundation prioritizes imperative research areas with the greatest potential impact for patients, including identifying genetic and immune contributions to these conditions, and biomarker discovery and validation. Chronic, multisystem disorders are caused by dysregulated communication between the nervous, immune, endocrine and gastrointestinal systems and simultaneously affect multiple body systems, resulting in complex illnesses that are difficult to diagnose and treat. There are no cures for these conditions and treatment options remain severely limited.
Contact Information:
Kainoa Clark
Chief Marketing Officer [email protected]
801-473-2119
CONCORD, Ohio, January 18, 2024 (Newswire.com)
-
Dolbey, a leading provider of healthcare documentation solutions, is excited to announce the newest addition to the Dolbey team, Jennifer Cooper. Jennifer will work as Program Manager with previous experience as the Director of Health Information Management at Hunt Regional, a longtime partner of Dolbey. She brings a decade of managerial expertise and a proven track record of exceptional leadership in clinical documentation improvement (CDI) and hospital coding programs.
Mrs. Cooper’s past involvement as a former Dolbey customer at Hunt Regional gives her a unique perspective on the needs and expectations of our clientele. Her expertise will also play a crucial role in enhancing Dolbey’s product installations and processes, ultimately benefiting our customers.
“I am thrilled to join the Dolbey team and contribute to the ongoing success of a company that I have long admired,” says Jennifer. “Having been a former Dolbey customer at Hunt Regional, I have witnessed firsthand the impact of Dolbey’s solutions on healthcare workflows. Now, as a member of the Dolbey team, I am excited to bring my knowledge and outlook as a former customer to help drive innovation, improve future product installations, and enhance processes. It’s the beginning of an exciting journey, and I look forward to being a part of Dolbey’s commitment to delivering exceptional healthcare solutions.”
In her role as Program Manager, Jennifer will be instrumental in driving advancements and efficiency across Dolbey’s clinical documentation solutions. She will be an invaluable asset as Dolbey continues to focus on improving future product installations and processes to meet the ever-changing needs in healthcare.
About Dolbey Dolbey’s award-winning healthcare suite of solutions improves productivity while delivering better documentation which improves patient care. Since 1914, Dolbey has consistently evolved its products incorporating the latest technologies available to meet the demands of the healthcare community. Today, our suite of products includes CAC, CDI, speech recognition, dictation and transcription.
For further information, please contact: Traci Miller, Marketing Director 800-878-7828 x119/ [email protected] www.dolbey.com
Contact Information:
Traci Miller
Marketing Director [email protected]
(800) 878-7828
Dr. Dennis Deruelle has been selected as the new Chief Medical Officer of Mendota Health and will address the tremendous need for wound care in this country by leading our national mobile advanced wound care clinic.
CHICAGO, January 18, 2024 (Newswire.com)
-
Chronic wounds affect 10.5 million U.S. Medicare beneficiaries. This is an increase of 2.3 million since 2014 and has an estimated annual cost of $28 billion. The management of individuals experiencing chronic wounds poses an economic challenge for the healthcare system, places a significant financial strain on society, and adversely affects both the quality of life and work productivity of affected individuals.
Dr. Dennis Deruelle has been selected as the new Chief Medical Officer of Mendota Health and will address the tremendous need for wound care in this country by leading our national mobile advanced wound care clinic.
Wound care is more than just medical treatment; it is a holistic endeavor influenced by social determinants that shape individuals’ lives. It involves a complex interplay of medical treatment, environmental factors, and individual circumstances. The impact of social determinants of health on wound care is a crucial yet often overlooked aspect of healthcare delivery. One of the most critical barriers to wound care is the ability to access the care. Traveling to a healthcare facility can be time-consuming, expensive, or even impossible for patients. By offering medical services at home, Mendota Health eliminates these barriers and ensures everyone has equal access to quality care. In addition, wound healing is a team endeavor; it takes the participation of the patient, their buy-in and cooperation, to heal the wound. Deruelle says, “I focus my effort bringing the patient onto the team, understanding their needs and centering care around them. I like to enable the individual in that way and create shared decision-making.”
As Mendota Health’s Chief Medical Officer, Dr. Deruelle will lead a nationwide group of nurse practitioners to address the wound care epidemic in the United States.
“I believe the actual hands-on future of health care is going to transition more and more to nurse practitioners,” says Deruelle. Dr. Deruelle has over 20 years of experience leading provider groups including having served as the owner of a private hospital medicine practice. “Nurse Practitioners are paramount to healthcare. And my message to them is you’re vital. You’re so important. You’re well trained and you’re capable.” In wound care, nurse practitioners outperform doctors when healing wounds. Advanced wound care at Mendota Health is provided by specialized nurse practitioners. Nurse practitioners who specialize in wound care have a 93% healing rate compared to 67% healing rate for physicians.
As the cannabis-themed “toasted” sub-concept prepares to light up another year of slingin’ dank food and chill vibes, it’s marking the occasion by raising money for the cannabis criminal justice reform non-profit organization.
FORT COLLINS, Colo., January 15, 2024 (Newswire.com)
-
Although cannabis has come a long way since Scott Jennings, the founder of Cheba Hut, sparked up his first toaster over 26 years ago, the brand acknowledges that there is still a long road ahead towards full justice reform for the plant and its common users. Thousands of Americans are still serving extended prison sentences for previous charges of the plant, even in states where marijuana is now decriminalized.
For the third year in a row, Cheba Hut, the cannabis-themed sandwich & bar concept with more than 60+ locations spread across the U.S., is joining forces with Last Prisoner Project to help correct these cannabis-related injustices. This non-profit organization leverages legal intervention, public education, and legislative advocacy in support of one single mission: to set free every last one of the tens of thousands of people locked up for possession of marijuana.
Last Prisoner Project expressed gratitude saying, “We are lucky to have the support of countless cannabis brands, dispensaries, and outspoken individuals who constantly find new ways to help accomplish our mission of freeing every last prisoner. We are honored to continue this partnership with Cheba Hut and continue the tradition of SmokeOut InJustice Day!”
Three years ago, Cheba Hut designated their anniversary on January 20th as SmokeOut InJustice Day and could not be more thrilled to continue the tradition this year! On Saturday, January 20th, all participating Cheba Hut shops will donate $2 of every entree sold to the Last Prisoner Project. This includes both in-shop and delivery entrees.
Last year, Cheba Hut raised over $100,000 in funds for LPP, after being matched by Dutchie. This year, other brands that support LPP have teamed up with Cheba Hut to show their support. The list includes Dime Bags, Native Roots, King Palm, and Wana Brands.
Nancy Whiteman, co-founder & CEO of Wana Brands and founder of Wana Brands Foundation explains, “The Wana Brands Foundation and Wana Brands are committed to the Last Prisoners Project’s mission that no one should be incarcerated for offenses that are now legal. Our contributions alongside Cheba Hut will provide financial support for the people exiting the prison system as well as their families with the goal of breaking the cycle of continued oppression due to the incarceration of a family member. This collaboration with Cheba Hut goes beyond mere fundraising; it is an active endeavor to foster positive change in communities and advance essential social reform.”
Additionally, Wana Brands is donating $25,000 to LPP and will be onsite at certain Cheba Hut shops on 1/20/24.
Brian Loeb, Cheba Hut’s Vice President of Marketing explains, “Although SOIJ is only three years old now, the event has rooted deep into the fabric of Cheba culture through our customers and crews. SmokeOut InJustice is about giving back to the many good people peacefully fighting against outdated legal systems, while simultaneously celebrating the monumental progress that is taking place every single day. In addition to our incredible partners, we'd like to thank each and every customer who drops in Saturday, January 20th to help the Hut SmokeOut InJustice!”
Whether you order a White Widow to enjoy on your couch or grab some homies and hit up your local Cheba Hut to show support, mark your calendars for Saturday, January 20th, and SmokeOut InJustice with Cheba Hut.
Revolutionary Service Aims to Catalyze Men’s Love Lives, Providing Professional Image Consulting and Coaching for an Impressive First Date
AUSTIN, Texas, January 15, 2024 (Newswire.com)
-
Austin's leading matchmaker, Something More, helmed by CEO Julia McCurley, has rolled out an innovative service - The Dating Prep Program for Men. This service enables men to make a lasting first impression by offering a blend of date coaching and image consulting. The Dating Prep Program is a comprehensive 10-hour initiative architected to improve all facets of a man's dating life, focusing particularly on in-person interactions.
With the digital age and its conventional bios taking a backseat, the program shines a spotlight on the importance of personal charisma and an exciting real-life persona. The ultimate goal is to enhance male clients' attractiveness and confidence, guiding them to establish and manage real relationships with the women they aspire for.
Divided into two sections, the Dating Prep Program entails five hours of strategic Personalized Date Coaching Sessions, topics covering conversation catalysts, friend zone evasion, first impression and charisma building, attraction creation, and a Mock Date with our expert female date coach. An extensive four-hour comprehensive image/wardrobe analysis follows this, assessing body type, effective colors to wear, outfit suggestions, date outfits, and grooming recommendations curated personally by Cris Coleman, the owner of Dolce Salon in Austin TX.
This robust program culminates in a 1-hour wrap-up consultation with CEO/Certified Matchmaker Julia McCurley. She reviews progress, discusses personalized dating strategies, and ensures a concrete action plan for the client's dating journey. This specialized program offered in Austin warrants an investment of $4,995.00.
Crafted with precision and expertise, Something More's Dating Prep Program is more than just a mere dating guide. It navigates through the intricate facets of dating and relationships, equipping men with essential dating skills while also emphasizing non-verbal communication, such as body language. For those seeking to redefine their dating experience, it acts as a powerful catalyst.
For more information about Something More's matchmaking services and the Dating Prep Program, please reach out to [email protected] or call 512-810-8803.
CEO and Certified Matchmaker Julia McCurley has been in the offline matchmaking business for over a decade. "We take our client relationships very seriously because their emotional love life is serious business to them - and to us," says McCurley.
Contact Information:
Lance Avery Morgan
Texas Luxury Lifestyle Expert, Creative Director and Editor-In-Chief [email protected]
5128108803
The new device offers additional features for use in both the exam room and the operating room.
The SunTech Vet40 Surgical Vital Signs Monitor for Companion Animals This versatile surgical vital signs monitor for companion animals is ideal for both exam and operating rooms. The Vet40 enhances veterinary care with comprehensive monitoring features, including NIBP, temperature, SpO2, ECG, and optional ETCO2.
MORRISVILLE, N.C., January 13, 2024 (Newswire.com)
-
SunTech is introducing the Vet40 surgical vital signs monitor for companion animals. This new monitor will expand on the features of the clinically validated SunTech Vet BP products.
The veterinary monitor uses SunTech’s Advantage Vet blood pressure, an animal-specific algorithm, to provide accurate readings on companion animals. To better manage nervous animals, the Vet40 features extremely quiet operations, with the option to turn off or customize alarms and audible indicators.
The Vet40 is designed for measuring a patient’s vital signs in the operating room while being portable enough to be used in exam rooms or other areas. The Vet40 combines SunTech’s non-invasive blood pressure, temperature, pulse oximetry (SpO2), electrocardiogram (ECG), and optional end-tidal carbon dioxide (ETCO2) and respiratory rate capabilities for monitoring before, during, and after a procedure. The monitor is also equipped to program automatic readings at intervals during a monitoring period.
The Vet40 is both portable and rechargeable. It features a 5-inch touchscreen and the ability to connect to an external display to increase the size of the viewing screen. The monitor can retain up to 960 data points and 48 waveform traces, even when powered down. Using Bluetooth connectivity or a USB-C wired connection, data can be transferred to a reporting PC application for printing or saving reports.
SunTech will be showcasing the new Vet40 at the Veterinary Meeting & Expo (VMX) in Orlando, Florida (from January 14-17, 2024) and at the Western Veterinary Conference (WVC) in Las Vegas, Nevada (from February 19-21 2024).
The Vet40 is for use only by or on the direction of a licensed veterinarian. For more information on SunTech Medical’s full line of clinical-grade, non-invasive blood pressure products and technologies, call 1-800-421-8626 or visit www.suntechmed.com.
